(KRYS) Krystal Biotech complete technical analysis [charts+indicators] | Buy/Sell Krystal Biotech | (KRYS) share price targets
Complete technical analysis of Krystal Biotech (KRYS) by charts plus indicators, forecast predictions and share price targets for Krystal Biotech (KRYS)
Krystal Biotech trades in USA in Health Care sector.
Showing technical analysis as on 2024-08-12 View latest technical analysis
10 day averaged volume of Krystal Biotech is 363658
Date | Daily Closing Price | Open | High | Low | Volume |
12 Mon Aug 2024 | 184.41 | 182.37 | 186.86 | 180.43 | 0.382 times |
09 Fri Aug 2024 | 182.17 | 180.68 | 184.18 | 179.99 | 0.397 times |
08 Thu Aug 2024 | 180.37 | 177.64 | 181.51 | 174.42 | 0.675 times |
07 Wed Aug 2024 | 174.70 | 182.35 | 185.17 | 174.20 | 0.948 times |
06 Tue Aug 2024 | 178.61 | 182.40 | 184.31 | 174.15 | 0.999 times |
05 Mon Aug 2024 | 180.71 | 165.00 | 184.39 | 164.81 | 2.856 times |
02 Fri Aug 2024 | 191.94 | 190.51 | 195.08 | 186.81 | 1.321 times |
01 Thu Aug 2024 | 198.78 | 208.77 | 209.07 | 196.59 | 1.198 times |
31 Wed Jul 2024 | 208.46 | 204.60 | 212.06 | 201.48 | 0.577 times |
30 Tue Jul 2024 | 202.89 | 205.46 | 206.56 | 199.87 | 0.489 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 185.3, but if it comes above 185.3, then a intra day buy could be more profitable.
If you take a sell trade below 185.3, then use 185.3 as stoploss and 170.4 as target. However if you take a buy trade in stock , then use 185.3 as stoploss and 197.68 as target.
Share price targets for Krystal Biotech (KRYS)
Target Type | Value |
Downside Target | 144.00 |
Downside Target | 152.94 |
Downside Target | 160.32 |
Downside Target | 164.81 |
Downside Target | 174.50 |
Downside Target | 180.43 |
Upside Target | 191.78 |
Upside Target | 198.00 |
Upside Target | 203.36 |
Upside Target | 209.07 |
Upside Target | 213.52 |
Upside Target | 214.98 |
Upside Target | 219.34 |
Intraday share price targets for Krystal Biotech (KRYS)
Target Type | Value |
Downside Intraday Target | 180.94 |
Downside Intraday Target | 177.47 |
Upside Intraday Target | 187.37 |
Upside Intraday Target | 190.33 |
Downside Intraday Target | 183.9 |
Weekly technical analysis of Krystal Biotech (KRYS)
Date | Weekly Closing Price | Open | High | Low | Volume |
12 Mon Aug 2024 | 184.41 | 182.37 | 186.86 | 180.43 | 0.065 times |
09 Fri Aug 2024 | 182.17 | 165.00 | 185.17 | 164.81 | 1.424 times |
02 Fri Aug 2024 | 191.94 | 213.52 | 213.52 | 186.81 | 0.994 times |
26 Fri Jul 2024 | 213.66 | 204.42 | 219.34 | 203.36 | 1.006 times |
19 Fri Jul 2024 | 203.66 | 201.73 | 214.98 | 198.00 | 0.957 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Krystal Biotech (KRYS)
Date | Monthly Closing Price | Open | High | Low | Volume |
12 Mon Aug 2024 | 184.41 | 208.77 | 209.07 | 164.81 | 0.508 times |
31 Wed Jul 2024 | 208.46 | 183.86 | 219.34 | 176.00 | 0.46 times |
28 Fri Jun 2024 | 183.64 | 161.81 | 191.78 | 160.32 | 2.427 times |
31 Fri May 2024 | 160.05 | 152.16 | 174.50 | 144.00 | 1.02 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Krystal Biotech (KRYS)
Price action analysis of Krystal Biotech ( (KRYS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Krystal Biotech ( (KRYS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Krystal Biotech ( (KRYS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Krystal Biotech ( (KRYS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Krystal Biotech stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Krystal Biotech in short term and the sell signal is strong.
Krystal Biotech Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Krystal Biotech in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Krystal Biotech is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 186.53 and Krystal Biotech (KRYS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Krystal Biotech (KRYS) stock. Volume based technical analysis of Krystal Biotech (KRYS) stock is negative.
Krystal Biotech Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Krystal Biotech ( (KRYS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Krystal Biotech ( (KRYS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Krystal Biotech ( (KRYS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Krystal Biotech ( (KRYS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Krystal Biotech stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Krystal Biotech in short term and the sell signal is strong.
Krystal Biotech Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Krystal Biotech in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Krystal Biotech is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 186.53 and Krystal Biotech (KRYS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Krystal Biotech (KRYS) stock. Volume based technical analysis of Krystal Biotech (KRYS) stock is negative.
Krystal Biotech Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.